Neurology
Found 4 results
Filters: Keyword is Immunoglobulin G  [Clear All Filters]
2019
Mielke O, Bril V, Cornblath DR, Lawo J-P, van Geloven N, Hartung H-P, Lewis RA, Merkies ISJ, Sobue G, Durn B et al..  2019.  Restabilization treatment after intravenous immunoglobulin withdrawal in chronic inflammatory demyelinating polyneuropathy: Results from the pre-randomization phase of the Polyneuropathy And Treatment with Hizentra study.. J Peripher Nerv Syst. 24(1):72-79.
2017
Kappos L, Havrdova E, Giovannoni G, Khatri BO, Gauthier SA, Greenberg SJ, You X, Wang P, Giannattasio G.  2017.  No evidence of disease activity in patients receiving daclizumab versus intramuscular interferon beta-1a for relapsing-remitting multiple sclerosis in the DECIDE study.. Mult Scler. 23(13):1736-1747.
2013
Reardon J, Perumal JS.  2013.  Review of daclizumab and its therapeutic potential in the treatment of relapsing-remitting multiple sclerosis.. Drug Des Devel Ther. 7:1187-93.
1975
Jaton JC, Huser H, Blatt Y, Pecht I.  1975.  Circular dichroism and fluorescence studies of homogeneous antibodies to type III pneumococcal polysaccharide.. Biochemistry. 14(24):5308-11.